FFCP PHASE1:Hg19::chr1:75045269..75045282,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=127254 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_protein_coding | |||
|HGNC=25346 | |||
|TSSclassifier=not | |||
|UniProt= | |||
|association_with_transcript=164bp_to_ENST00000433746_5end | |||
|coexpression_cluster_id=C156 | |||
|description=CAGE_peak_19_at_C1orf173_5end | |||
|id=chr1:75045269..75045282,- | |||
|ontology_enrichment_celltype=CL:0000946!8.95e-20!1;CL:0000786!8.95e-20!1;CL:0000980!8.95e-20!1;CL:0000945!1.66e-12!24;CL:0000826!1.66e-12!24;CL:0000785!1.43e-10!2;CL:0000955!1.43e-10!2;CL:0000818!1.43e-10!2;CL:0000954!1.43e-10!2;CL:0000816!1.43e-10!2;CL:0000817!1.82e-07!3;CL:0002615!2.05e-07!3 | |||
|ontology_enrichment_celltype_v019=CL:0000946;1.23e-66;1!CL:0000786;1.23e-66;1!CL:0002615;3.66e-23;3!CL:0000945;3.86e-12;24 | |||
|ontology_enrichment_celltype_v019_2=CL:0000946,1.23e-66,1;CL:0000786,1.23e-66,1;CL:0000980,1.23e-66,1;CL:0000785,3.61e-34,2;CL:0000955,3.61e-34,2;CL:0000818,3.61e-34,2;CL:0000954,3.61e-34,2;CL:0000816,3.61e-34,2;CL:0000817,2.62e-23,3;CL:0002615,4.09e-23,3;CL:0000945,3.75e-12,24;CL:0000826,3.75e-12,24 | |||
|ontology_enrichment_development_v019=CL:0000954;3.61e-34;2 | |||
|ontology_enrichment_disease=DOID:2355!1.08e-19!1;DOID:630!1.56e-19!1;DOID:0050177!1.56e-19!1;DOID:0050427!1.56e-19!1;DOID:74!1.57e-10!2;DOID:0060058!3.37e-08!10 | |||
|ontology_enrichment_disease_v019=DOID:2355;3.34e-66;1!DOID:74;5.96e-34;2!DOID:1287;9.45e-18;4!DOID:0060058;6.34e-08;10 | |||
|ontology_enrichment_disease_v019_2=DOID:2355,2.39e-66,1;DOID:74,5.04e-34,2;DOID:1287,8.69e-18,4;DOID:0060058,6.13e-08,10 | |||
|ontology_enrichment_uberon=UBERON:0002106!2.97e-07!3;UBERON:0004854!2.97e-07!3;UBERON:0009034!2.97e-07!3;UBERON:0002095!2.97e-07!3;UBERON:0004782!2.97e-07!3;UBERON:0003281!2.97e-07!3;UBERON:0009664!2.97e-07!3;UBERON:0002296!2.97e-07!3;UBERON:0005602!2.97e-07!3;UBERON:0001179!2.97e-07!3;UBERON:0006293!2.97e-07!3;UBERON:0004457!5.81e-07!12;UBERON:0000042!5.81e-07!12 | |||
|ontology_enrichment_uberon_v019=UBERON:0003688;2.59e-12;6!UBERON:0002358;2.59e-12;6!UBERON:0003684;2.59e-12;6!UBERON:0001178;2.59e-12;6!UBERON:0004457;1.16e-08;9!UBERON:0000042;1.16e-08;9 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0003688,2.74e-12,6;UBERON:0002358,2.74e-12,6;UBERON:0003684,2.74e-12,6;UBERON:0001178,2.74e-12,6;UBERON:0004457,8.38e-07,12;UBERON:0000042,8.38e-07,12 | |||
|phase1_expression=0,0,0,1.0007329835313,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0654895377488563,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.277064115484183,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.201799707191048,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.123084805461069,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.69346664131569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0634158101939068,0,0,0,0,0,0,0,0,0,0,5.64646539023318,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0999411559249289,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.267964130156178,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.320568492303233 | |||
|short_description=p19@C1orf173 | |||
}} |
Revision as of 19:06, 10 January 2014
Short description: | p19@C1orf173 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_19_at_C1orf173_5end |
Coexpression cluster: | C156_plasma_splenic_hereditary_B_large_xeroderma_b |
Association with transcript: | 164bp_to_ENST00000433746_5end |
EntrezGene: | C1orf173 |
HGNC: | 25346 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
antibody secreting cell | 1.23e-66 | 1 |
plasma cell | 1.23e-66 | 1 |
plasmablast | 1.23e-66 | 1 |
mature B cell | 3.61e-34 | 2 |
pre-B-II cell | 3.61e-34 | 2 |
transitional stage B cell | 3.61e-34 | 2 |
small pre-B-II cell | 3.61e-34 | 2 |
immature B cell | 3.61e-34 | 2 |
precursor B cell | 2.62e-23 | 3 |
adipocyte of omentum tissue | 4.09e-23 | 3 |
lymphocyte of B lineage | 3.75e-12 | 24 |
pro-B cell | 3.75e-12 | 24 |
Ontology term | p-value | n |
---|---|---|
omentum | 2.74e-12 | 6 |
peritoneum | 2.74e-12 | 6 |
abdominal cavity | 2.74e-12 | 6 |
visceral peritoneum | 2.74e-12 | 6 |
cavity lining | 8.38e-07 | 12 |
serous membrane | 8.38e-07 | 12 |
Ontology term | p-value | n |
---|---|---|
anemia | 2.39e-66 | 1 |
hematopoietic system disease | 5.04e-34 | 2 |
cardiovascular system disease | 8.69e-18 | 4 |
lymphoma | 6.13e-08 | 10 |